Immunoinformatics-Driven Design of an HPV-16 and -18 Synthetic Long Peptide Vaccine
Background and Aim: Human papillomavirus types 16 and 18 cause most cervical cancers worldwide. Existing VLP-based vaccines are unable to eliminate ongoing highly oncogenic infections. This study suggests an SLP-based vaccine for already infected patients, even with precancerous lesions. Methods: HP...
Main Authors: | Alexandru TÎRZIU, Leonard MADA, Corina VERNIC, Virgil PĂUNESCU |
---|---|
Format: | Article |
Language: | English |
Published: |
Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca
2023-09-01
|
Series: | Applied Medical Informatics |
Subjects: | |
Online Access: | https://ami.info.umfcluj.ro/index.php/AMI/article/view/973 |
Similar Items
-
Design of a Synthetic Long Peptide Vaccine Targeting HPV-16 and -18 Using Immunoinformatic Methods
by: Alexandru Tîrziu, et al.
Published: (2023-06-01) -
Immunoinformatics Study on Early 4 Protein of Human Papillomavirus Type 16 for Cervical Cancer Vaccine Peptide Candidate
by: Yani Suryani, et al.
Published: (2019-11-01) -
Clinical Significance of an HPV DNA Chip Test with Emphasis on HPV-16 and/or HPV-18 Detection in Korean Gynecological Patients
by: Min-Kyung Yeo, et al.
Published: (2016-07-01) -
Cytotoxic T-Cell-Based Vaccine against SARS-CoV-2: A Hybrid Immunoinformatic Approach
by: Alexandru Tirziu, et al.
Published: (2022-01-01) -
Prevalência dos HPV 16, 18, 45 e 31 em mulheres com lesão cervical Prevalence of HPV 16, 18, 45 and 31 in women with cervical lesions
by: Denise Rocha Pitta, et al.
Published: (2010-07-01)